NCT00397072View on ClinicalTrials.gov

Epothilone in Recurrent Glioblastoma Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

March 31, 2008

Study Completion Date

December 31, 2008

Conditions
Glioblastoma
Interventions
DRUG

ZK 219477

Trial Locations (1)

20133

Istituto Nazionale Neurologico, Milan

All Listed Sponsors
lead

Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

OTHER

NCT00397072 - Epothilone in Recurrent Glioblastoma Patients | Biotech Hunter | Biotech Hunter